-
August 23, 2012
Phase One Solutions, a new company offering early- and late-phase clinical research services to biopharmaceutical and medical device organisations, has set up in Miami, US on the basis of an asset sale by PRACS Institute, the newly constituted Cetero Research.
Full story
-
June 26, 2012
Cetero Research has completed its planned asset sale to lenders, overhauled the company’s management, changed its identity and relocated its headquarters.
Full story
-
April 26, 2012
Cetero Research has reached a final resolution with the US Food and Drug Administration over the disputed bioanalytical studies behind the company’s financial decline.
Full story
-
March 27, 2012
Cetero Research, the early-phase contract research organisation (CRO) hit last year by FDA claims of “significant instances of misconduct and violations” at the company’s facility in Houston, Texas, has filed for Chapter 11 bankruptcy protection amid mounting financial problems.
Full story
-
August 02, 2011
Early-phase contract research organisation Cetero Research has hit back at the US Food and Drug Administration for representing as pervasive misconduct what Cetero insists was an isolated incident of data falsification at its bioanalytical laboratory in Houston, Texas.
Full story
-
July 28, 2011
Drugs tested in trials by Cetero Research are under the spotlight after a US investigation found the contract research organisation falsified data and manipulated samples.
Full story
-
August 26, 2010
Early-stage contract research organisation Cetero Research has expanded its Clinical Dermatology and Transdermal Drug Delivery System (TDDS) services to four of its clinical facilities in the US and Canada.
Full story